Appearing as a promising breakthrough in the struggle against obesity, the drug is capturing considerable attention . It combines properties of two established GLP-1 receptor agonists, liraglutide, and an unique glucose-dependent hormonal component. Initial clinical results have indicated significant weight decrease in patients with obesity , poss